View ValuationExosens 향후 성장Future 기준 점검 4/6Exosens (는) 각각 연간 16.6% 및 11.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 17.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 20.4% 로 예상됩니다.핵심 정보16.6%이익 성장률17.06%EPS 성장률Aerospace & Defense 이익 성장25.8%매출 성장률11.6%향후 자기자본이익률20.42%애널리스트 커버리지Good마지막 업데이트22 Jul 2026최근 향후 성장 업데이트공고 • Feb 23+ 1 more updateExosens Provides Earnings Guidance for the Year 2026Exosens provided earnings guidance for the year 2026. For the period, the company expects Revenue in the range of €520 million to €540 million.공고 • Oct 28Exosens Provides Revenue Guidance for 2024Exosens provided revenue guidance for 2024. For the year, the company expects high-teens organic revenue growth and around 30% total revenue growth including 2024 acquisitions.공고 • Jul 24Exosens Reiterates Revenue Guidance for 2024Exosens reiterated revenue guidance for 2024. Based on this strong revenue growth in the first semester, the company reiterates its outlook of high-teens organic revenue growth in the upper 15%-20% range and around 30% of total revenue growth including the contribution over 12 months of acquisitions made in 2024.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • 3hInvestor sentiment improves as stock rises 15%After last week's 15% share price gain to €64.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 31x in the Aerospace & Defense industry in Germany. Total returns to shareholders of 65% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €90.88 per share.Buy Or Sell Opportunity • Jun 15Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €60.10. The fair value is estimated to be €77.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 96%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.공고 • May 29Exosens Approves Cash Dividend, Payable on 29 May 2026Exosens at its Combined General Meeting held on 22 May 2026, approved the payment of a cash dividend of €0.30 per share, with payment commencing on 29 May 2026.Upcoming Dividend • May 21Upcoming dividend of €0.30 per shareEligible shareholders must have bought the stock before 27 May 2026. Payment date: 29 May 2026. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (0.9%).Declared Dividend • May 21Dividend increased to €0.30Dividend of €0.30 is 200% higher than last year. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.5%, which is lower than the industry average of 1.4%. Payout Ratios Payout ratio: 22%. Cash payout ratio: 30%.공고 • Apr 27Exosens (ENXTPA:EXENS) acquired Emberion Oy.Exosens (ENXTPA:EXENS) acquired Emberion Oy on April 24, 2026. For the period ending December 31, 2025, Emberion Oy reported total revenue of approximately €0.7 million. Exosens (ENXTPA:EXENS) completed the acquisition of Emberion Oy on April 24, 2026.공고 • Apr 21Exosens, Annual General Meeting, May 22, 2026Exosens, Annual General Meeting, May 22, 2026. Location: 83 avenue marceau, paris France공고 • Feb 23+ 1 more updateExosens Provides Earnings Guidance for the Year 2026Exosens provided earnings guidance for the year 2026. For the period, the company expects Revenue in the range of €520 million to €540 million.공고 • Jan 08Theon International Plc (ENXTAM:THEON) completed the acquisition of 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA.Theon International Plc (ENXTAM:THEON) entered into a definitive agreement to acquire 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA for approximately €270 million on October 11, 2025. The purchase price is a cash consideration of €268.7 million corresponding to €54 per share. Following the completion of the transaction, THEON will become the second largest shareholder in EXOSENS, after Groupe HLD. In connection with the transaction, UBS Europe SE and Citibank Europe PLC have agreed to provide a bridge facility, which is intended to be refinanced with a combination of debt and newly issued equity within existing shareholders’ authorizations. The closing of the transaction remains subject to regulatory notifications in a selected number of countries and is expected to take place in early Q1 2026. UBS Europe SE acted as financial advisor for Theon International Plc. Clifford Chance LLP acted as legal advisor for Theon International Plc. Theon International Plc (ENXTAM:THEON) completed the acquisition of 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA on January 7, 2026.공고 • Jan 06Exosens to Report Q3, 2026 Results on Oct 27, 2026Exosens announced that they will report Q3, 2026 results on Oct 27, 2026공고 • Oct 28Exosens (ENXTPA:EXENS) acquired Noxant SAS.Exosens (ENXTPA:EXENS) acquired Noxant SAS on March 13, 2025. Exosens (ENXTPA:EXENS) completed the acquisition of Noxant SAS on March 13, 2025.공고 • Sep 10Exosens Launches Its New 5G Image Intensifier TubeExosens announced the launch of its 5G image intensifier tube, offering unrivalled overall performance in the field of night vision. 5G tubes introduce major advances that could redefine the operational capabilities of armed forces. They offer a significant improvement in overall performance (known as FOM) of 30% and an increase of up to 35% in detection ranges, regardless of the night level (from 1 to 5) compared to current standard intensifier tubes. With this new technology, visual comfort is unparalleled: thanks to innovations in manufacturing processes and high-end components, 5G tubes offers even sharper images. There is a significant reduction in "noise" or "flicker," especially in low-light conditions, by improving the perception of textures, contrasts, and depth. This increase in comfort significantly reduces visual fatigue and mental strain, and enhances soldier mobility through improved perception of the environment and ground contours. With the war in Ukraine demonstrating the need to modernize the equipment of European land forces, 5G technology is set to become the product of choice for special forces and the future standard for night vision within all armed forces. With orders already confirmed ahead of its official launch, 5G is already proving popular with its first users. The design of 5G is also a French industrial achievement: it is the product of cutting-edge innovations, mastered from end-to-end in France, which will contribute to the upgrading and strengthening of the European armed forces and their allies. This innovation reinforces the ability of armed forces to act with precision, efficiency, and security in increasingly complex environments.공고 • Aug 28Exosens (ENXTPA:EXENS) signed an agreement to acquire Phasics.Exosens (ENXTPA:EXENS) signed an agreement to acquire Phasics on August 27, 2025.공고 • Jul 30+ 1 more updateExosens to Report First Half, 2026 Results on Jul 28, 2026Exosens announced that they will report first half, 2026 results on Jul 28, 2026공고 • May 24Exosens announces Annual dividend, payable on May 30, 2025Exosens announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.공고 • Apr 19Exosens, Annual General Meeting, May 23, 2025Exosens, Annual General Meeting, May 23, 2025. Location: 83 avenue marceau, paris France공고 • Mar 22Exosens to Report Q3, 2025 Results on Oct 27, 2025Exosens announced that they will report Q3, 2025 results on Oct 27, 2025공고 • Mar 04Exosens Proposes Cash Dividend for the Fiscal Year 2024Exosens Board of Directors decided, during its meeting on 28 February 2025, to propose the payment of a €0.10 cash dividend per share for the 2024 fiscal year. This amount will be subject to the approval of the Annual General Shareholders' Meeting, which will take place on 23 May 2025.공고 • Mar 03+ 1 more updateExosens to Report First Half, 2025 Results on Jul 31, 2025Exosens announced that they will report first half, 2025 results on Jul 31, 2025공고 • Jan 24Exosens' Brand Photonis Launches Two Market-Leading Solutions to Advance Single Photon Detection and Imaging ApplicationsPhotonis, a leading brand of Exosens and global leader in advanced photon detection and imaging solutions announced the launch of Crickettm Pro and PhotonPixtm. Designed to redefine the possibilities of single photon detection and imaging, these cutting-edge solutions empower researchers and industry professionals to achieve unparalleled performance across applications such as biomedical imaging, quantum science, and high-energy physics. These technologies will officially debut at SPIE Photonics West 2025 in San Francisco, CA. The Crickettm Pro brings unprecedented imaging capabilities for low-light and single-photon imaging applications. This innovative, plug-and-play image intensifier adapter easily fits any professional, scientific, F-Mount camera, delivering high resolution and ultra-high-speed functionality for demanding low-light applications. Key features of the Crickettm Pro include: Expanded 25 mm active detection area; High-speed gating as fast as 3 nanoseconds; Rem remarkable 3 MHz Burst or 30kHz repetition rate; Matched with High-performance Photonis Image Intensifier; F-Mount lens/camera interface; Fully integrated power and gating electronics. With these enhancements, Crickettm Pro sets a new benchmark for scientific imaging, providing precise, rapid, and reliable performance tailored for researchers and industry professionals. PhotonPixtm: Ultra High-Count Rate Module for Single-Photon Detection; PhotonPix also introduces PhotonPixtm, a high-count rate MCP-PMT-based plug-and-play module engineered for ultra-high timing precision single-photon detection. Combining technology with user-centric design, PhotonPix offers: An O8 mm sensitive area; Extreme-low dark count rate as low as 20 cps; Count rates exceeding 200 MHz in Burst mode, making it ideal for high-demand applications; Timing resolution below 15 ps for unmatched precision; PhotonPixtm is ideal for ultra-fast Single Photon Detection and time-correlated applications such as LIDAR, Photon Entanglement, or Lifetime Imaging. The module's versatility accommodates various high-quantum-efficiency (Hi-QE) photocathodes from Photonis, covering the spectrum range from 150nm to 900nm, making it the perfect fit for researchers and industry professionals.공고 • Jan 08+ 2 more updatesExosens to Report Q1, 2025 Results on Apr 28, 2025Exosens announced that they will report Q1, 2025 results Pre-Market on Apr 28, 2025공고 • Nov 19Exosens Reportedly in Talks to Buy NoxantExosens (ENXTPA:EXENS) has entered into exclusive talks on the acquisition for an undisclosed amount of Noxant (Noxant SAS). The contemplated deal is aimed at bolstering Exosens' technology platform with the addition of advanced cooled infrared camera cores for OEM partners, particularly in the Midwave Infrared (MWIR) range. Noxant’s technology serves applications in surveillance, scientific research and industrial testing, as well as in gas detection. The parties anticipate finalising a deal in the coming months, subject to the completion of the consultation of the employees’ representative body of Noxant and customary regulatory approvals.공고 • Oct 29Exosens to Report Fiscal Year 2024 Results on Mar 03, 2025Exosens announced that they will report fiscal year 2024 results Pre-Market on Mar 03, 2025공고 • Oct 28Exosens Provides Revenue Guidance for 2024Exosens provided revenue guidance for 2024. For the year, the company expects high-teens organic revenue growth and around 30% total revenue growth including 2024 acquisitions.Reported Earnings • Sep 03First half 2024 earnings releasedFirst half 2024 results: Net income: €2.90m (up €2.90m from 1H 2023). Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Aerospace & Defense industry in Germany.공고 • Sep 03Exosens (ENXTPA:EXENS) acquired LR Tech Inc.Exosens (ENXTPA:EXENS) acquired LR Tech Inc. on September 1, 2024. Exosens' product line in cooled infrared technology is intended to be enhanced by this acquisition. Exosens (ENXTPA:EXENS) completed the acquisition of LR Tech Inc. on September 1, 2024.공고 • Aug 01Exosens (ENXTPA:EXENS) acquired Centronic Limited.Exosens (ENXTPA:EXENS) acquired Centronic Limited on August 1, 2024. Exosens (ENXTPA:EXENS) completed the acquisition of Centronic Limited on August 1, 2024.공고 • Jul 24Exosens Reiterates Revenue Guidance for 2024Exosens reiterated revenue guidance for 2024. Based on this strong revenue growth in the first semester, the company reiterates its outlook of high-teens organic revenue growth in the upper 15%-20% range and around 30% of total revenue growth including the contribution over 12 months of acquisitions made in 2024.Board Change • Jun 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.이익 및 매출 성장 예측DB:H8Y - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028688126981661012/31/2027608106751381012/31/202653688611271012/31/20254687050100N/A6/30/20254325657101N/A3/31/2025413415699N/A12/31/2024383295494N/A9/30/2024374144885N/A6/30/2024354-34074N/A3/31/202432323062N/A12/31/202329272050N/A12/31/202220112647N/A12/31/2021166-1492343N/A12/31/2020150-163044N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: H8Y 의 연간 예상 수익 증가율(16.6%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: H8Y 의 연간 수익(16.6%)이 German 시장(15.9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: H8Y 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: H8Y 의 수익(연간 11.6%)이 German 시장(연간 6.6%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: H8Y 의 수익(연간 11.6%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: H8Y의 자본 수익률은 3년 후 20.4%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YCapital-goods 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 03:20종가2026/07/23 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Exosens는 15명의 분석가가 다루고 있습니다. 이 중 10명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Amelie Dueckelmann-DublanyBerenbergAleksander PetercBernsteinLaurent GelebartBNP Paribas12명의 분석가 더 보기
공고 • Feb 23+ 1 more updateExosens Provides Earnings Guidance for the Year 2026Exosens provided earnings guidance for the year 2026. For the period, the company expects Revenue in the range of €520 million to €540 million.
공고 • Oct 28Exosens Provides Revenue Guidance for 2024Exosens provided revenue guidance for 2024. For the year, the company expects high-teens organic revenue growth and around 30% total revenue growth including 2024 acquisitions.
공고 • Jul 24Exosens Reiterates Revenue Guidance for 2024Exosens reiterated revenue guidance for 2024. Based on this strong revenue growth in the first semester, the company reiterates its outlook of high-teens organic revenue growth in the upper 15%-20% range and around 30% of total revenue growth including the contribution over 12 months of acquisitions made in 2024.
Valuation Update With 7 Day Price Move • 3hInvestor sentiment improves as stock rises 15%After last week's 15% share price gain to €64.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 31x in the Aerospace & Defense industry in Germany. Total returns to shareholders of 65% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €90.88 per share.
Buy Or Sell Opportunity • Jun 15Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €60.10. The fair value is estimated to be €77.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 96%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
공고 • May 29Exosens Approves Cash Dividend, Payable on 29 May 2026Exosens at its Combined General Meeting held on 22 May 2026, approved the payment of a cash dividend of €0.30 per share, with payment commencing on 29 May 2026.
Upcoming Dividend • May 21Upcoming dividend of €0.30 per shareEligible shareholders must have bought the stock before 27 May 2026. Payment date: 29 May 2026. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (0.9%).
Declared Dividend • May 21Dividend increased to €0.30Dividend of €0.30 is 200% higher than last year. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.5%, which is lower than the industry average of 1.4%. Payout Ratios Payout ratio: 22%. Cash payout ratio: 30%.
공고 • Apr 27Exosens (ENXTPA:EXENS) acquired Emberion Oy.Exosens (ENXTPA:EXENS) acquired Emberion Oy on April 24, 2026. For the period ending December 31, 2025, Emberion Oy reported total revenue of approximately €0.7 million. Exosens (ENXTPA:EXENS) completed the acquisition of Emberion Oy on April 24, 2026.
공고 • Apr 21Exosens, Annual General Meeting, May 22, 2026Exosens, Annual General Meeting, May 22, 2026. Location: 83 avenue marceau, paris France
공고 • Feb 23+ 1 more updateExosens Provides Earnings Guidance for the Year 2026Exosens provided earnings guidance for the year 2026. For the period, the company expects Revenue in the range of €520 million to €540 million.
공고 • Jan 08Theon International Plc (ENXTAM:THEON) completed the acquisition of 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA.Theon International Plc (ENXTAM:THEON) entered into a definitive agreement to acquire 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA for approximately €270 million on October 11, 2025. The purchase price is a cash consideration of €268.7 million corresponding to €54 per share. Following the completion of the transaction, THEON will become the second largest shareholder in EXOSENS, after Groupe HLD. In connection with the transaction, UBS Europe SE and Citibank Europe PLC have agreed to provide a bridge facility, which is intended to be refinanced with a combination of debt and newly issued equity within existing shareholders’ authorizations. The closing of the transaction remains subject to regulatory notifications in a selected number of countries and is expected to take place in early Q1 2026. UBS Europe SE acted as financial advisor for Theon International Plc. Clifford Chance LLP acted as legal advisor for Theon International Plc. Theon International Plc (ENXTAM:THEON) completed the acquisition of 9.8% stake in Exosens (ENXTPA:EXENS) from Invest Gamma, HLD Europe S.C.A. and Invest Prince Henri SCA on January 7, 2026.
공고 • Jan 06Exosens to Report Q3, 2026 Results on Oct 27, 2026Exosens announced that they will report Q3, 2026 results on Oct 27, 2026
공고 • Oct 28Exosens (ENXTPA:EXENS) acquired Noxant SAS.Exosens (ENXTPA:EXENS) acquired Noxant SAS on March 13, 2025. Exosens (ENXTPA:EXENS) completed the acquisition of Noxant SAS on March 13, 2025.
공고 • Sep 10Exosens Launches Its New 5G Image Intensifier TubeExosens announced the launch of its 5G image intensifier tube, offering unrivalled overall performance in the field of night vision. 5G tubes introduce major advances that could redefine the operational capabilities of armed forces. They offer a significant improvement in overall performance (known as FOM) of 30% and an increase of up to 35% in detection ranges, regardless of the night level (from 1 to 5) compared to current standard intensifier tubes. With this new technology, visual comfort is unparalleled: thanks to innovations in manufacturing processes and high-end components, 5G tubes offers even sharper images. There is a significant reduction in "noise" or "flicker," especially in low-light conditions, by improving the perception of textures, contrasts, and depth. This increase in comfort significantly reduces visual fatigue and mental strain, and enhances soldier mobility through improved perception of the environment and ground contours. With the war in Ukraine demonstrating the need to modernize the equipment of European land forces, 5G technology is set to become the product of choice for special forces and the future standard for night vision within all armed forces. With orders already confirmed ahead of its official launch, 5G is already proving popular with its first users. The design of 5G is also a French industrial achievement: it is the product of cutting-edge innovations, mastered from end-to-end in France, which will contribute to the upgrading and strengthening of the European armed forces and their allies. This innovation reinforces the ability of armed forces to act with precision, efficiency, and security in increasingly complex environments.
공고 • Aug 28Exosens (ENXTPA:EXENS) signed an agreement to acquire Phasics.Exosens (ENXTPA:EXENS) signed an agreement to acquire Phasics on August 27, 2025.
공고 • Jul 30+ 1 more updateExosens to Report First Half, 2026 Results on Jul 28, 2026Exosens announced that they will report first half, 2026 results on Jul 28, 2026
공고 • May 24Exosens announces Annual dividend, payable on May 30, 2025Exosens announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.
공고 • Apr 19Exosens, Annual General Meeting, May 23, 2025Exosens, Annual General Meeting, May 23, 2025. Location: 83 avenue marceau, paris France
공고 • Mar 22Exosens to Report Q3, 2025 Results on Oct 27, 2025Exosens announced that they will report Q3, 2025 results on Oct 27, 2025
공고 • Mar 04Exosens Proposes Cash Dividend for the Fiscal Year 2024Exosens Board of Directors decided, during its meeting on 28 February 2025, to propose the payment of a €0.10 cash dividend per share for the 2024 fiscal year. This amount will be subject to the approval of the Annual General Shareholders' Meeting, which will take place on 23 May 2025.
공고 • Mar 03+ 1 more updateExosens to Report First Half, 2025 Results on Jul 31, 2025Exosens announced that they will report first half, 2025 results on Jul 31, 2025
공고 • Jan 24Exosens' Brand Photonis Launches Two Market-Leading Solutions to Advance Single Photon Detection and Imaging ApplicationsPhotonis, a leading brand of Exosens and global leader in advanced photon detection and imaging solutions announced the launch of Crickettm Pro and PhotonPixtm. Designed to redefine the possibilities of single photon detection and imaging, these cutting-edge solutions empower researchers and industry professionals to achieve unparalleled performance across applications such as biomedical imaging, quantum science, and high-energy physics. These technologies will officially debut at SPIE Photonics West 2025 in San Francisco, CA. The Crickettm Pro brings unprecedented imaging capabilities for low-light and single-photon imaging applications. This innovative, plug-and-play image intensifier adapter easily fits any professional, scientific, F-Mount camera, delivering high resolution and ultra-high-speed functionality for demanding low-light applications. Key features of the Crickettm Pro include: Expanded 25 mm active detection area; High-speed gating as fast as 3 nanoseconds; Rem remarkable 3 MHz Burst or 30kHz repetition rate; Matched with High-performance Photonis Image Intensifier; F-Mount lens/camera interface; Fully integrated power and gating electronics. With these enhancements, Crickettm Pro sets a new benchmark for scientific imaging, providing precise, rapid, and reliable performance tailored for researchers and industry professionals. PhotonPixtm: Ultra High-Count Rate Module for Single-Photon Detection; PhotonPix also introduces PhotonPixtm, a high-count rate MCP-PMT-based plug-and-play module engineered for ultra-high timing precision single-photon detection. Combining technology with user-centric design, PhotonPix offers: An O8 mm sensitive area; Extreme-low dark count rate as low as 20 cps; Count rates exceeding 200 MHz in Burst mode, making it ideal for high-demand applications; Timing resolution below 15 ps for unmatched precision; PhotonPixtm is ideal for ultra-fast Single Photon Detection and time-correlated applications such as LIDAR, Photon Entanglement, or Lifetime Imaging. The module's versatility accommodates various high-quantum-efficiency (Hi-QE) photocathodes from Photonis, covering the spectrum range from 150nm to 900nm, making it the perfect fit for researchers and industry professionals.
공고 • Jan 08+ 2 more updatesExosens to Report Q1, 2025 Results on Apr 28, 2025Exosens announced that they will report Q1, 2025 results Pre-Market on Apr 28, 2025
공고 • Nov 19Exosens Reportedly in Talks to Buy NoxantExosens (ENXTPA:EXENS) has entered into exclusive talks on the acquisition for an undisclosed amount of Noxant (Noxant SAS). The contemplated deal is aimed at bolstering Exosens' technology platform with the addition of advanced cooled infrared camera cores for OEM partners, particularly in the Midwave Infrared (MWIR) range. Noxant’s technology serves applications in surveillance, scientific research and industrial testing, as well as in gas detection. The parties anticipate finalising a deal in the coming months, subject to the completion of the consultation of the employees’ representative body of Noxant and customary regulatory approvals.
공고 • Oct 29Exosens to Report Fiscal Year 2024 Results on Mar 03, 2025Exosens announced that they will report fiscal year 2024 results Pre-Market on Mar 03, 2025
공고 • Oct 28Exosens Provides Revenue Guidance for 2024Exosens provided revenue guidance for 2024. For the year, the company expects high-teens organic revenue growth and around 30% total revenue growth including 2024 acquisitions.
Reported Earnings • Sep 03First half 2024 earnings releasedFirst half 2024 results: Net income: €2.90m (up €2.90m from 1H 2023). Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Aerospace & Defense industry in Germany.
공고 • Sep 03Exosens (ENXTPA:EXENS) acquired LR Tech Inc.Exosens (ENXTPA:EXENS) acquired LR Tech Inc. on September 1, 2024. Exosens' product line in cooled infrared technology is intended to be enhanced by this acquisition. Exosens (ENXTPA:EXENS) completed the acquisition of LR Tech Inc. on September 1, 2024.
공고 • Aug 01Exosens (ENXTPA:EXENS) acquired Centronic Limited.Exosens (ENXTPA:EXENS) acquired Centronic Limited on August 1, 2024. Exosens (ENXTPA:EXENS) completed the acquisition of Centronic Limited on August 1, 2024.
공고 • Jul 24Exosens Reiterates Revenue Guidance for 2024Exosens reiterated revenue guidance for 2024. Based on this strong revenue growth in the first semester, the company reiterates its outlook of high-teens organic revenue growth in the upper 15%-20% range and around 30% of total revenue growth including the contribution over 12 months of acquisitions made in 2024.
Board Change • Jun 13Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.